Targeting Bruton Tyrosine Kinase: A novel strategy in the treatment of B-cell lymphomas
Authors
R. Sklavenitis-Pistofidis
1st Laboratory of Pharmacology, Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
T. Koletsa
Department of Pathology, Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
A. Lazaridou
1st Laboratory of Pharmacology, Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
A. Goulas
1st Laboratory of Pharmacology, Faculty of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
Language: English
Page range: 7 - 14
Submitted on: Sep 8, 2016
Accepted on: Aug 24, 2017
Published on: Jun 30, 2017
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Related subjects:
© 2017 R. Sklavenitis-Pistofidis, T. Koletsa, A. Lazaridou, A. Goulas, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.